Kalaris Therapeutics, Inc. (KLRS)
2.235
-0.02
(-1.11%)
USD |
NASDAQ |
Oct 13, 14:59
Kalaris Therapeutics Price : 2.235 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 2.37 | 2.37 | 2.22 | 2.26 | 122092.0 |
| Oct 09, 2026 | 2.46 | 2.55 | 2.36 | 2.36 | 104426.0 |
| Oct 08, 2026 | 2.60 | 2.60 | 2.35 | 2.50 | 109961.0 |
| Oct 07, 2026 | 2.59 | 2.693 | 2.53 | 2.56 | 74117.00 |
| Oct 06, 2026 | 2.90 | 2.93 | 2.61 | 2.66 | 103434.0 |
| Oct 05, 2026 | 2.72 | 2.89 | 2.58 | 2.83 | 27389.00 |
| Oct 02, 2026 | 2.90 | 2.90 | 2.51 | 2.70 | 235897.0 |
| Oct 01, 2026 | 2.88 | 2.89 | 2.76 | 2.85 | 58622.00 |
| Sep 30, 2026 | 2.87 | 2.97 | 2.75 | 2.89 | 102557.0 |
| Sep 29, 2026 | 2.84 | 2.91 | 2.835 | 2.90 | 51803.00 |
| Sep 28, 2026 | 2.91 | 2.97 | 2.81 | 2.845 | 92778.00 |
| Sep 25, 2026 | 3.024 | 3.09 | 2.91 | 2.92 | 49252.00 |
| Sep 24, 2026 | 3.13 | 3.162 | 3.02 | 3.07 | 33587.00 |
| Sep 23, 2026 | 3.20 | 3.21 | 3.12 | 3.12 | 24129.00 |
| Sep 22, 2026 | 3.225 | 3.285 | 3.16 | 3.24 | 29136.00 |
| Sep 21, 2026 | 3.20 | 3.30 | 3.09 | 3.245 | 88632.00 |
| Sep 18, 2026 | 3.18 | 3.23 | 3.04 | 3.20 | 234395.0 |
| Sep 17, 2026 | 3.20 | 3.27 | 3.13 | 3.16 | 43336.00 |
| Sep 16, 2026 | 3.150 | 3.25 | 3.10 | 3.18 | 61745.00 |
| Sep 15, 2026 | 3.35 | 3.355 | 3.20 | 3.20 | 109362.0 |
| Sep 14, 2026 | 3.41 | 3.445 | 3.25 | 3.30 | 57633.00 |
| Sep 11, 2026 | 3.39 | 3.44 | 3.27 | 3.38 | 95102.00 |
| Sep 10, 2026 | 3.55 | 3.66 | 3.30 | 3.30 | 60821.00 |
| Sep 09, 2026 | 3.66 | 3.68 | 3.45 | 3.47 | 82984.00 |
| Sep 08, 2026 | 3.88 | 3.90 | 3.60 | 3.63 | 100721.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Replimune Group, Inc. | 12.18 |
| Arrowhead Pharmaceuticals, Inc. | 58.56 |
| Oncolytics Biotech, Inc. | 0.4945 |
| Sangamo Therapeutics, Inc. | 0.15 |
| Sarepta Therapeutics, Inc. | 16.62 |
Price Related Metrics
| Price to Book Value | 0.9225 |
| Earnings Yield | -90.12% |
| Market Cap | 53.20M |